Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes - PubMed (original) (raw)

Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes

Darina Bassil et al. Dermatoendocrinol. 2013.

Abstract

Background: The Middle East and North Africa (MENA) region registers some of the highest rates of hypovitaminosis D worldwide.

Aim: We systematically reviewed the prevalence of hypovitaminosis D, rickets and osteomalacia, their predictors and impact on major outcomes, in the region.

Methods: Medline, Pubmed and Embase search engines, entering keywords and concepts, combined with individual countries of interest, were used. Search was limited years 2000-2012; and review articles were used for the period preceding year 2000.

Results: Rickets and osteomalacia still occur in this sunny region. Hypovitaminosis D prevails, with rates varying 30-90%, considering a desirable serum 25 hydroxy-vitamin D [25(OH)D] of 20 ng/ml. Advancing age, female gender, multi-parity, clothing style, season, socio-economic status and urban living are recognized predictors of hypovitaminosis D in adults. Prolonged breastfeeding without vitamin D supplementation and low dietary calcium intake are the recognized risk factors for rickets and hypovitaminosis D in children.. Associations with pain score and disease activity in rheumatologic disorders, viral load and interleukins in hepatitis C, BMI, lipids and insulin sensitivity, blood pressure, heart failure and mortality are described. Sun exposure in adults decreased prevalence of metabolic syndrome in one study. Few randomized vitamin D trials revealed that the majority of mothers or children failed to achieve a desirable 25(OH)D level, even with doses by far exceeding current recommendations. A trial in adolescent girls reveals substantial bone and lean mass increments.

Conclusion: Hypovitaminosis D is prevalent in MENA. The lack of populations based studies, gaps in studies in infants, pre-pubertal children and pregnant women, hinder the development of region specific guidelines and constitute a major obstacle to impact this chronic and most often subclinical disease.

Keywords: genetics polymorphisms; infections; musculoskeletal outcomes; osteomalacia; pleotropic; policy; prevalence; region specific guidelines; rickets; risk factors.

PubMed Disclaimer

Figures

None

Figure 1. Serum 25(OH)D Levels in Adults (A) and Children (B) Based on Color Codes. The color codes are: green > 30 ng/ml, yellow 20–29 ng/ml, orange 10–19 ng/ml, and red < 10 ng/ml. To convert from ng/ml to nmol multiply by 2.5. The color codes were selected based on mean or median results from population based studies available or as obtained from most representative studies for each country. For countries with varying results, the color code was chosen as valid for ≥ 50% of reported values; or more than one color code was used (for, e.g., children in Iran).

Similar articles

Cited by

References

    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81. doi: 10.1056/NEJMra070553. - DOI - PubMed
    1. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364:248–54. doi: 10.1056/NEJMcp1009570. - DOI - PubMed
    1. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25:585–91. doi: 10.1016/j.beem.2011.05.002. - DOI - PubMed
    1. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 2010;235:1034–45. doi: 10.1258/ebm.2010.010014. - DOI - PubMed
    1. Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man. J Bone Miner Res. 2008;23:974–9. doi: 10.1359/jbmr.080420. - DOI - PubMed

LinkOut - more resources